IAI Accepts, published online ahead of print on 26 October 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Zhang, W.
Right arrow Articles by Robertson, D. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, W.
Right arrow Articles by Robertson, D. C.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00497-09
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Genetic fusions of LTAB and STa toxoids of porcine enterotoxigenic Escherichia coli (ETEC) elicited neutralizing anti-LT and anti-STa antibodies

Weiping Zhang*, Chengxian Zhang, David H. Francis, Ying Fang, David Knudsen, James P. Nataro, and Donald C. Robertson

Department of Veterinary Science/The Center for Infectious Disease Research & Vaccinology, South Dakota State University, Brookings, SD; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MA; Department of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS

* To whom correspondence should be addressed. Email: weiping.zhang{at}sdstate.edu.


arrow
Abstract

Enterotoxigenic Escherichia coli (ETEC) strains are a major cause of diarrhea disease in humans and farm animals. E. coli fimbriae or colonization factor antigens (CFAs) and enterotoxins including heat-labile (LT) and heat-stable (ST) are the key virulence factors in ETEC diarrhea. Unlike fimbriae or LT, STa has not been much included as an antigen in vaccine development against ETEC diarrhea because of its poor immunogenicity. STa becomes immunogenic only after being coupled with a strongly immunogenic carrier protein. However, native or shorter STa antigens either had to retain toxic activity in order to become antigenic or elicited anti-STa antibodies that were not sufficiently protective. In this study, we genetically mutated porcine LT (pLT) gene for a pLT192(R->G) toxoid and STa (pSTa) gene for three full-length pSTatoxoids [STa11(N->K), STa12(P->F), and STa13(A->Q)], and used the full-length pLT192 as an adjuvant to carry the pSTatoxoid for ‘pLT192:pSTa-toxoid’ fusion antigens. Rabbits immunized with ‘pLT192:pSTa12’ or ‘pLT192:pSTa13 fusion protein developed high titers of anti-LT and anti-STa antibodies. Furthermore, rabbit antiserum and antifecal antibodies were able to neutralize purified cholera toxin (CT) and STa toxin. In addition, preliminary data suggested that suckling piglets born from a sow immunized with the ‘pLT192:pSTa13 fusion antigen were protected when challenged with a STa-positive ETEC. This study demonstrated that pSTa toxoids are antigenic when fused with a pLT toxoid, and elicited anti-LT and anti-STa antibodies were protective. This fusion strategy could provide instructive information to develop effective toxoid vaccines against ETEC associated diarrhea in animals and humans.